共 108 条
[1]
Orejarena LA(1998)Paroxysmal supraventricular tachycardia in the general population J Am Coll Cardiol 31 150-157
[2]
Vidaillet H(2007)U.S. emergency department visits for supraventricular tachycardia, 1993–2003 Acad Emerg Med Off J Soc Acad Emerg Med 14 578-581
[3]
DeStefano F(2006)Clinical practice. Supraventricular tachycardia N Engl J Med 354 1039-1051
[4]
Nordstrom DL(1992)Adenosine and the treatment of supraventricular tachycardia Am J Med 92 655-664
[5]
Vierkant RA(2001)Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia J Am Coll Cardiol 37 548-553
[6]
Smith PN(2001)Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo Am Heart J 142 93-98
[7]
Hayes JJ(1982)Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial Ann Intern Med 96 409-412
[8]
Murman DH(1984)Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil Am J Cardiol 54 1138-1139
[9]
McDonald AJ(1994)Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group Am J Cardiol 74 578-584
[10]
Pelletier AJ(1991)Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy Ann Intern Med 114 539-544